Health

Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries

* Cerapro® is a patented, skin pH-lowering cream approved for the treatment of atopic dermatitis under the EuropeanMedical Device Regulation (CE Mark) * Product launch targeted for 2026 in six European markets, including Switzerland, Austria, the Netherlands and Belgium.  SINGAPORE, Jan. 5, 20...

2026-01-05 17:30 6462

Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC

CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) in combination wi...

2026-01-05 17:29 12737

ScinoPharm Secures U.S. FDA Approval for Glatiramer Acetate Injection for the Treatment of Multiple Sclerosis

TAINAN, Jan. 5, 2026 /PRNewswire/ -- ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food and Drug Administration (FDA) approval for Glatiramer Acetate Injection, a treatment for Multiple Sclerosis (MS), making it the onl...

2026-01-05 14:00 5895

GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy

HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application...

2026-01-05 12:07 9994

WuXi Biologics Achieves ISO 20400 Certification, Setting Benchmark in Sustainable Procurement

WUXI, China, Jan. 4, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK) announced it has achieved ISO 20400 Sustainable Procurement certification, an internationally recognized standard that integrates sustainability principles into procurement practices and promotes transparency and responsibility ac...

2026-01-05 11:57 4812

C&R Research, the 'K-Clinical Hub', Strengthens Partnerships in Indonesia

Accelerating Indonesia Collaboration through Global Clinical Capabilities SEOUL, South Korea, Jan. 5, 2026 /PRNewswire/ -- C&R Research, founded in 1997 as Korea's first full-service Contract Research Organization (CRO), has played a pivotal role in advancing the Korean clinical trial industry an...

2026-01-05 10:00 8153

Insilico Medicine Announce US$888 Million Multi-Year Collaboration with Servier for Drug Discovery and Development in Oncology

* Insilico Medicine achieved an R&D collaboration with Servier valued at up to US$888 million, focused on discovering and developing innovative oncology therapies, by combining Insilico's AI-driven drug discovery platforms with Servier's global expertise in cancer drug development.  * Under t...

2026-01-05 08:30 5032

Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes

-The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the efficacy, safety, and tolerability of ASC30 in participants with diabetes. Enrollment is expected to begin in the first quarter of 2026. -ASC30 demonstrated placebo-...

2026-01-05 08:10 9423

Babies Bliss Establishes a New Standard for Fertility Wellness in Singapore with a Whole-Person, Cycle-Aware Model

Singapore-based Fertility Wellness House positions complementary care as long-term support alongside IVF and assisted fertility treatments SINGAPORE, Jan. 5, 2026 /PRNewswire/ -- Babies Bliss, a leading fertility wellness house inSingapore, is redefining how fertility journeys are supported thro...

2026-01-05 07:00 4107

Daingt Co., Ltd. Launches New Gim Products Based on Raw Material Data, Expanding Its Quality-Focused Lineup

SEOUL, South Korea, Jan. 4, 2026 /PRNewswire/ -- Daingt Co., Ltd. announced the launch of new gim (seaweed) products developed based on its accumulated production experience and raw material data. The newly introduced products were developed by actively leveraging Daingt's extensive database of ...

2026-01-04 08:00 8177

EXOSYSTEMS' exoRehab Named a CES Innovation Awards 2026 Honoree in Digital Health

AI-powered wearable brings clinic-grade muscle tracking to at-home rehab. Live demos Jan. 6–9 at CES 2026. SEOUL, South Korea, Jan. 3, 2026 /PRNewswire/ -- EXOSYSTEMS Inc. announced that exoRehab, its Remote Therapeutic Monitoring (RTM) solution for musculoskeletal care, has been selected as a C...

2026-01-03 23:27 3118

Sumbu Unveils World's First Dual-Vector Consumer Exoskeleton at CES 2026

Exo-S3 lineup brings AI-powered, lightweight leg assistance to the market LAS VEGAS, Jan. 3, 2026 /PRNewswire/ -- Today at CES 2026, Sumbu announced its Exo-S3 line of dual-vector exoskeletons designed for the general public: the Exo-S3, Exo-S3 Pro and Exo-S3 Ultra. The series is the world's firs...

2026-01-03 19:00 3253

Bebird Launches EarSight Ultra X: The 5G-Powered Ear Care Solution for Modern Families Pursuing a Quality Life

Next-Generation Device Combines Unprecedented Visual Clarity with Enhanced Safety for Proactive Family Wellness NEW YORK, Jan. 1, 2026 /PRNewswire/ -- Bebird, the global innovator in smart personal care, today announces the launch of EarSight Ultra X

2026-01-02 01:00 709

ImmunoForge to Host Strategic Partnering Meetings During J.P. Morgan Healthcare Conference 2026

* Focusing on global out-licensing of Phase 2 assets PF1801 and PF1804. * Company to engage with global big pharma in San Francisco to accelerate U.S. clinical entry. SEOUL, South Korea, Jan. 1, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd. (Co-CEOs Sung-Min Ahn and Kiho Chang), a clinical-stage ...

2026-01-01 14:00 3221

Rising Through Challenge: Living Phoenix's 2026 New Year Message POGMENT Biomimetic Collagen

CHENGDU, China, Jan. 1, 2026 /PRNewswire/ -- As the Year of the Horse begins, bringing new momentum and promise,Living Phoenix—a pioneer in next-generation biomaterials—wishes all friends, partners, and users a joyful New Year. May you stay young, steady, and ready to gallop forward into 2026. ...

2026-01-01 12:36 8432

POGMENT Biomimic Collagen Reacquired Recognition, Founder Appointed as Industrial Mentor for Master's Students at East China Normal University, Awarded 2025 Innovation Leadership Award

CHENGDU, China, Dec. 31, 2025 /PRNewswire/ -- On December 27, the 2025 Master of Engineering Management (MEM) Industry Mentor Orientation and Appointment Ceremony was held at the Wenshi Building on the Putuo Campus of East China Normal University (ECNU), located at No. 3663 Zhongshan North Road, ...

2025-12-31 17:21 10402

Life-Space TrioBiotic Series Lands in Southeast Asia, Revolutionizing Gut Health with Triple-Action Formula

BANGKOK, Dec. 31, 2025 /PRNewswire/ -- A significant shift is underway in the regional health and wellness landscape as the innovative Life-Space TrioBiotic supplement series officially enters the Southeast Asian market. The launch introduces a cutting-edge "three-in-one" approach to gut health, ...

2025-12-31 15:46 9533

KLMBio Accelerates Global Expansion in Bone Graft Market with Human Tissue-Based Medical Devices

SEOUL, South Korea, Dec. 31, 2025 /PRNewswire/ -- KLMBio, a manufacturer and exporter of human tissue-based medical devices, is accelerating its global business expansion by strengthening its high-value tissue-based product portfolio to target the rapidly growing global bone graft market. The gl...

2025-12-31 12:44 4181

Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

SHANGHAI, Dec. 31, 2025 /PRNewswire/ -- Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company of Qiming Venture Partners, today successfully listed on the Hong Kong Stock Exchange (HKEX). The listing marks the largest biotech IPO on theHong Kong stock m...

2025-12-31 08:55 12179

Entering the New Year, VARON Strengthens Commitment to Dependable Oxygen Support

NEW YORK, Dec. 30, 2025 /PRNewswire/ -- As the new year begins, it offers a meaningful moment to reflect on shared progress and renewed responsibility in respiratory care. Over the past year, VARON has continued to focus on what matters most—rel...

2025-12-31 07:34 4842
1 ... 45464748495051 ... 872

Week's Top Stories